GAiT – News & Events

13 Dec 1205559188375646208

Thanks to all who participated in the iPSC Quality Round Data Discussion calls this week! Minutes will be sent out Monday.

Reply on Twitter 1205559188375646208 Retweet on Twitter 1205559188375646208 Like on Twitter 12055591883756462082 Twitter 1205559188375646208

GAiT @IPSCtherapies·

13 Dec 1205400495122198528

A Quality Round update was just sent to Participants. We remind those doing retests to upload the data template sheets in addition to raw data.

Reply on Twitter 1205400495122198528 Retweet on Twitter 1205400495122198528 Like on Twitter 12054004951221985281 Twitter 1205400495122198528

Retweet on Twitter GAiT Retweeted

BioInformant @StemCellMarket·

1 Dec 1201260084384415744

Tokyo's Heartseed reaps $26M to test its iPS cell injections for heart failure - The company forms spherical clusters of heart cells from purified, allogeneic iPSCs, which are injected into the heart muscle wall.

https://www.fiercebiotech.com/medtech/tokyo-s-heartseed-reaps-26m-to-test-its-stem-cell-injections-for-heart-failure

Reply on Twitter 1201260084384415744 Retweet on Twitter 12012600843844157447 Like on Twitter 120126008438441574410 Twitter 1201260084384415744

GAiT @IPSCtherapies·

9 Dec 1204065286028242945

We are very grateful for @NIBSC_MHRA, @MCRI_for_kids, @yposkesi, @nyscf, @Inserm, and @cmrb for joining the first two Quality Round data discussion calls today. Your comments and feedback have been documented.

Reply on Twitter 1204065286028242945 Retweet on Twitter 1204065286028242945 Like on Twitter 12040652860282429452 Twitter 1204065286028242945

GAiT @IPSCtherapies·

4 Dec 1202220815976161281

GAiT just sent an iPSC Quality Round Update to Participants from 18 sites across 11 countries informing them of the status of Quality re-tests, the data workshop, and manuscript preparation.

Reply on Twitter 1202220815976161281 Retweet on Twitter 1202220815976161281 Like on Twitter 12022208159761612811 Twitter 1202220815976161281

Retweet on Twitter GAiT Retweeted

BioInformant @StemCellMarket·

1 Dec 1201260486626611200

Kyoto University seeks government approval to conduct a clinical trial of transplanted cartilage made from iPS cells -

Kyoto Univ. seeks to use stem cells for damaged knee joint treatment

Kyoto University says it has asked for government approval to conduct a clinical trial of transplanting cartilage made from induced pluripotent stem c...

english.kyodonews.net

Reply on Twitter 1201260486626611200 Retweet on Twitter 120126048662661120010 Like on Twitter 12012604866266112009 Twitter 1201260486626611200

Retweet on Twitter GAiT Retweeted

New York Stem Cell Foundation Research Institute @nyscf·

21 Nov 1197560358740877315

We are looking for an associate scientist to work with #geneediting and #genomics on the NYSCF Global Stem Cell Array-- our automated system for #stemcell derivation, gene editing, and downstream differentiations. Learn more and apply here: http://bit.ly/33LS3Eg #STEMjobs

Reply on Twitter 1197560358740877315 Retweet on Twitter 11975603587408773152 Like on Twitter 11975603587408773154 Twitter 1197560358740877315

Retweet on Twitter GAiT Retweeted

CSCRM @KCLstemcells·

18 Nov 1196471394034495490

Do you want to #study & #work in the field of #RegenerativeMedicine? APPLY NOW to the
@wellcometrust funded "Advanced Therapies for Regenerative Medicine" course at the CSCRM

https://findaphd.com/phds/program/wellcome-trust-four-year-phd-programme-in-advanced-therapies-for-regenerative-medicine/?i132p2907…

@KCLBMBioscience
@KCLWP @KCLResDevHealth @kcldo1thing @kclwim @KCL_MRCDTP

Reply on Twitter 1196471394034495490 Retweet on Twitter 119647139403449549016 Like on Twitter 119647139403449549015 Twitter 1196471394034495490

GAiT @IPSCtherapies·

21 Nov 1197517183640854530

GAiT's new Director Annelise Bennaceur Griscelli (@Inserm) will be attending the RESTORE meeting (Berlin) next week & will be discussing GAiT's efforts to standardize iPSC manufacture for allogeneic therapeutic development. More on RESTORE here: https://apnews.com/f9aca5d5fb2fa4100b29480d221e5658

Reply on Twitter 1197517183640854530 Retweet on Twitter 1197517183640854530 Like on Twitter 11975171836408545301 Twitter 1197517183640854530

GAiT @IPSCtherapies·

18 Nov 1196389779186888704

If you are a Quality Round Participant and would like to discuss the Quality Round directly with GAiT before the planned conference calls, you can set up a direct meeting by emailing stephen.sullivan@gait.global

Reply on Twitter 1196389779186888704 Retweet on Twitter 1196389779186888704 Like on Twitter 1196389779186888704 Twitter 1196389779186888704

GAiT @IPSCtherapies·

15 Nov 1195371128069533702

Participants can now download slides from the GAiT website to promote their participation in the iPSC Quality Round 2019 http://www.gait.global/quality-round-data-portal/ (Participant log in required for access and download)

Reply on Twitter 1195371128069533702 Retweet on Twitter 1195371128069533702 Like on Twitter 1195371128069533702 Twitter 1195371128069533702

GAiT @IPSCtherapies·

14 Nov 1195028646379081733

iPSC Quality Round 2019: material for secondary testing is being dispatched Monday 18th November 2019.

Reply on Twitter 1195028646379081733 Retweet on Twitter 1195028646379081733 Like on Twitter 1195028646379081733 Twitter 1195028646379081733

Retweet on Twitter GAiT Retweeted

CCRM_au @CCRM_au·

11 Nov 1193809824066293760

The key to the #commercialization journey is actually in developing relationships with stakeholders through an understanding of priorities, rather than trying to be an expert in all areas. #regenmed #commercialization @MTPConnect_AUS

Reply on Twitter 1193809824066293760 Retweet on Twitter 11938098240662937608 Like on Twitter 119380982406629376015 Twitter 1193809824066293760

GAiT @IPSCtherapies·

8 Nov 1192886618593648640

It was useful to catch up with @BlueRockTx, @CGTCatapult and @CCRM_ca at the @ISSCR meeting in Toronto today. Three important participants in the iPSC #Quality Round 2019.

Reply on Twitter 1192886618593648640 Retweet on Twitter 1192886618593648640 Like on Twitter 11928866185936486404 Twitter 1192886618593648640

GAiT @IPSCtherapies·

8 Nov 1192823243520061443

Fate Tx opens new GMP facility for iPSC therapeutic development

Fate Therapeutics Announces the Opening of its cGMP Manufacturing Facility Dedicated to iPSC-derived Cell Therapies | Fate Therapeutics, Inc.

The Investor Relations website contains information about Fate Therapeutics, Inc.'s business for stockholders, potential investors, and financial anal...

ir.fatetherapeutics.com

Reply on Twitter 1192823243520061443 Retweet on Twitter 1192823243520061443 Like on Twitter 11928232435200614431 Twitter 1192823243520061443

GAiT @IPSCtherapies·

7 Nov 1192554760743923725

At the MARS Centre at the University of Toronto today, visiting @CCRM and holding discussions with other Canadian Participants of the iPSC Quality Round 2019 today and tomorrow.

Reply on Twitter 1192554760743923725 Retweet on Twitter 1192554760743923725 Like on Twitter 11925547607439237251 Twitter 1192554760743923725

Retweet on Twitter GAiT Retweeted

Michael May CCRM @MichaelMay5·

6 Nov 1192188657580625922

Congrats @StemCellNetwork for another successful TMM. As always, it is wonderful to work with you on the meeting. Thanks to all speakers and attendees. See you next year!

Reply on Twitter 1192188657580625922 Retweet on Twitter 11921886575806259221 Like on Twitter 11921886575806259228 Twitter 1192188657580625922

Retweet on Twitter GAiT Retweeted

Geoff Lomax @Geoff_Lomax·

6 Nov 1192113594026074120

Regulated, Reputable & Reliable how #stemcell treatments should be developed with proper regulatory oversight around the world #TMM2019 @StemCellNetwork nice overview from Health Canada